Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
0.635
-0.015 (-2.25%)
Dec 20, 2024, 4:00 PM EST - Market closed

Karyopharm Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
80993854861,1391,204
Upgrade
Market Cap Growth
-32.46%-74.26%-20.76%-57.36%-5.35%111.61%
Upgrade
Enterprise Value
2142015495951,0791,133
Upgrade
Last Close Price
0.640.863.406.4315.4819.17
Upgrade
PS Ratio
0.510.682.452.3210.5429.43
Upgrade
PB Ratio
-0.65-0.73-23.11-6.1022.5424.18
Upgrade
P/TBV Ratio
----22.5424.18
Upgrade
EV/Sales Ratio
1.441.383.502.849.9927.70
Upgrade
Debt / Equity Ratio
-1.68-2.27-18.72-3.944.043.98
Upgrade
Asset Turnover
0.650.490.470.680.360.13
Upgrade
Inventory Turnover
4.301.361.251.011.81-
Upgrade
Quick Ratio
2.693.165.053.434.355.82
Upgrade
Current Ratio
3.003.375.313.744.596.01
Upgrade
Return on Equity (ROE)
-----391.29%-171.36%
Upgrade
Return on Assets (ROA)
-34.27%-27.05%-26.79%-19.87%-35.33%-37.19%
Upgrade
Return on Capital (ROIC)
-49.55%-34.57%-33.60%-25.14%-42.72%-44.31%
Upgrade
Earnings Yield
-109.93%-144.44%-42.94%-25.54%-17.23%-16.58%
Upgrade
FCF Yield
-151.37%-93.59%-38.88%-22.09%-14.08%-15.87%
Upgrade
Buyback Yield / Dilution
-10.23%-39.51%-8.84%-4.41%-16.28%-9.11%
Upgrade
Total Shareholder Return
-10.23%-39.51%-8.84%-4.41%-16.28%-9.11%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.